BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31404537)

  • 1. Six1 is negatively correlated with poor prognosis and reduces 5-fluorouracil sensitivity via attenuating the stemness of hepatocellular carcinoma cells.
    Chen K; Wei H; Pan J; Chen Z; Pan D; Gao T; Huang J; Huang M; Ou M; Zhong W
    Eur J Pharmacol; 2019 Oct; 861():172599. PubMed ID: 31404537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six2 is negatively correlated with good prognosis and decreases 5-FU sensitivity via suppressing E-cadherin expression in hepatocellular carcinoma cells.
    Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
    Biomed Pharmacother; 2018 Aug; 104():204-210. PubMed ID: 29772441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.
    You Y; Zheng Q; Dong Y; Xie X; Wang Y; Wu S; Zhang L; Wang Y; Xue T; Wang Z; Chen R; Wang Y; Cui J; Ren Z
    Oncotarget; 2016 May; 7(22):32221-31. PubMed ID: 27050147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141.
    Wu L; Pan C; Wei X; Shi Y; Zheng J; Lin X; Shi L
    Cell Commun Signal; 2018 Aug; 16(1):47. PubMed ID: 30119680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.
    Hirata H; Sugimachi K; Takahashi Y; Ueda M; Sakimura S; Uchi R; Kurashige J; Takano Y; Nanbara S; Komatsu H; Saito T; Shinden Y; Iguchi T; Eguchi H; Atsumi K; Sakamoto K; Doi T; Hirakawa M; Honda H; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1402-9. PubMed ID: 25404478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma.
    Lai KP; Chen J; He M; Ching AK; Lau C; Lai PB; To KF; Wong N
    Int J Cancer; 2014 Oct; 135(8):1790-9. PubMed ID: 24585547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated fibroblasts promote the stemness of CD24
    Li Y; Wang R; Xiong S; Wang X; Zhao Z; Bai S; Wang Y; Zhao Y; Cheng B
    J Mol Med (Berl); 2019 Feb; 97(2):243-255. PubMed ID: 30564864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma.
    Ng KT; Man K; Sun CK; Lee TK; Poon RT; Lo CM; Fan ST
    Br J Cancer; 2006 Oct; 95(8):1050-5. PubMed ID: 17008870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
    Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
    Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High FOXK1 expression correlates with poor outcomes in hepatocellular carcinoma and regulates stemness of hepatocellular carcinoma cells.
    Cao H; Chu X; Wang Z; Guo C; Shao S; Xiao J; Zheng J; Zhang D
    Life Sci; 2019 Jul; 228():128-134. PubMed ID: 31054270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch2 is a crucial regulator of self-renewal and tumorigenicity in human hepatocellular carcinoma cells.
    Wu WR; Zhang R; Shi XD; Yi C; Xu LB; Liu C
    Oncol Rep; 2016 Jul; 36(1):181-8. PubMed ID: 27221981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCND1 silencing suppresses liver cancer stem cell differentiation and overcomes 5-Fluorouracil resistance in hepatocellular carcinoma.
    Ding H; Wang Y; Zhang H
    J Pharmacol Sci; 2020 Jul; 143(3):219-225. PubMed ID: 32418739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.
    Chang TS; Chen CL; Wu YC; Liu JJ; Kuo YC; Lee KF; Lin SY; Lin SE; Tung SY; Kuo LM; Tsai YH; Huang YH
    PLoS One; 2016; 11(2):e0149897. PubMed ID: 26919045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
    Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
    Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological significance of ezrin and SIX1 protein expression in alpha fetoprotein-negative hepatocellular carcinoma].
    Kong J; Zhou X; Han L; Quan C; Cui X; Lin Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):236-9. PubMed ID: 26927385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma.
    Jiang L; Shan J; Shen J; Wang Y; Yan P; Liu L; Zhao W; Xu Y; Zhu W; Su L; Chen J; Cheng F; Yao H; Xu H; Qian C; Liang Z
    Oncotarget; 2016 Jun; 7(24):36814-36828. PubMed ID: 27167111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High PGAM5 expression induces chemoresistance by enhancing Bcl-xL-mediated anti-apoptotic signaling and predicts poor prognosis in hepatocellular carcinoma patients.
    Cheng J; Qian D; Ding X; Song T; Cai M; Dan Xie ; Wang Y; Zhao J; Liu Z; Wu Z; Pang Q; Zhu L; Wang P; Hao X; Yuan Z
    Cell Death Dis; 2018 Sep; 9(10):991. PubMed ID: 30250224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STARD13 is positively correlated with good prognosis and enhances 5-FU sensitivity via suppressing cancer stemness in hepatocellular carcinoma cells.
    Gao F; Yu X; Meng R; Wang J; Jia L
    Onco Targets Ther; 2018; 11():5371-5381. PubMed ID: 30214243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.